ConductScience.org, home

Paper2201646

Experimental model of type IV Streptococcus agalactiae (group B streptococcus) infection in mice with early development of septic arthritis.

Tissi L and 8 others. Infect Immun, 1990. Cited by 40 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Experimental model of type IV Streptococcus agalactiae (group B streptococcus) infection in mice with early development of septic arthritis. Papers, record 2201646. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2201646

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Experimental model of type IV Streptococcus agalactiae (group B streptococcus) infection in mice with early development of septic arthritis.
PubMed
Journal
Infect Immun
PubMed
Year
1990
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
1.16
iCite
Revised in PubMed
2021-05-26
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tissi LL
2Marconi PP
3Mosci PP
4Merletti LL
5Cornacchione PP
6Rosati EE
7Recchia SS
8von Hunolstein CC
9Orefici GG

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arthritis, InfectiousMajor topic
Disease Models, AnimalMajor topic
MiceMajor topic
Rodent DiseasesMajor topic
Streptococcal InfectionsMajor topic
Streptococcus agalactiaeMajor topic
Animals
Antibodies, Bacterial
Chronic Disease
Female
Immunoglobulin G
Immunoglobulin M
Incidence
Kinetics
Male
Organ Specificity

Source PubMed

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16,155,334Mucin model for group B type III streptococcal infection in mice.Infect Immun1980https://conductscience.org/library/papers/6155334PubMed
26,407,330Rat arthritis due to whole group B streptococci. Clinical and histopathologic features compared with groups A and D.Am J Pathol1983https://conductscience.org/library/papers/6407330PubMed
34,572,747Group B streptococcal neonatal and infant infections.J Pediatr1973https://conductscience.org/library/papers/4572747PubMed
413,908,742Beta hemolytic streptococcus group B associated with problems of the perinatal period.Am J Obstet Gynecol1961https://conductscience.org/library/papers/13908742PubMed
52,494,110Isolation and characterization of type IV group B Streptococcus capsular polysaccharide.Infect Immun1989https://conductscience.org/library/papers/2494110PubMed
6324,367The emergence of group B streptococci in infections of the newborn infant.Annu Rev Med1977https://conductscience.org/library/papers/324367PubMed
73,542,351Animal models of infectious arthritis.Clin Rheum Dis1986https://conductscience.org/library/papers/3542351PubMed
8336,836Arthritis in rats after systemic injection of streptococcal cells or cell walls.J Exp Med1977https://conductscience.org/library/papers/336836PubMed
9773,831Experimental group B streptococcal infections in mice: hematogenous virulence and mucosal colonization.Infect Immun1976https://conductscience.org/library/papers/773831PubMed
1058,870Radioimmunoassay for measuring antibodies specific for group B streptococcal types Ia, Ib, Ic, II, and III.J Clin Microbiol1976https://conductscience.org/library/papers/58870PubMed
113,901,894The role of complement in opsonization of GBS.Antibiot Chemother (1971)1985https://conductscience.org/library/papers/3901894PubMed
126,991,426Production of bacteremia and meningitis in infant rats with group B streptococcal serotypes.Infect Immun1980https://conductscience.org/library/papers/6991426PubMed
13115,895New serotypes of group B streptococci isolated from human sources.J Clin Microbiol1979https://conductscience.org/library/papers/115895PubMed
143,901,909The nomenclature of GBS.Antibiot Chemother (1971)1985https://conductscience.org/library/papers/3901909PubMed
154,608,888Group B streptococcal infections in infants. The importance of the various serotypes.JAMA1974https://conductscience.org/library/papers/4608888PubMed
167,011,999Effects of route and time of administration of antiserum on protection of mice from lethal infection due to group B Streptococcus type III.Infect Immun1981https://conductscience.org/library/papers/7011999PubMed
176,995,304Kinetics of phagocyte response to group B streptococcal infections in newborn rats.Infect Immun1980https://conductscience.org/library/papers/6995304PubMed
18344,223Adult mice as a model for early onset group B streptococcal disease.Infect Immun1978https://conductscience.org/library/papers/344223PubMed
193,334,555Pathogenic factors in group B streptococci types IV and V.Chemioterapia1987https://conductscience.org/library/papers/3334555PubMed
20856,869Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus.J Clin Invest1977https://conductscience.org/library/papers/856869PubMed

See all 29 references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
20,658,182Possible protective role of chloramphenicol in TSST-1 and coagulase-positive Staphylococcus aureus-induced septic arthritis with altered levels of inflammatory mediators.Inflammation2011https://conductscience.org/library/papers/20658182PubMed
19,606,256IL-4 deficiency decreases mortality but increases severity of arthritis in experimental group B Streptococcus infection.Mediators Inflamm2009https://conductscience.org/library/papers/19606256PubMed
19,179,417Toll-like receptor 2 deficiency is associated with enhanced severity of group B streptococcal disease.Infect Immun2009https://conductscience.org/library/papers/19179417PubMed
15,501,766Glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, inhibits the progression of group B streptococcal arthritis.Infect Immun2004https://conductscience.org/library/papers/15501766PubMed
15,271,956Inhibition of nitric oxide synthase exacerbates group B streptococcus sepsis and arthritis in mice.Infect Immun2004https://conductscience.org/library/papers/15271956PubMed
14,500,523Streptococcus pyogenes infection induces septic arthritis with increased production of the receptor activator of the NF-kappaB ligand.Infect Immun2003https://conductscience.org/library/papers/14500523PubMed
12,540,577Infection by Streptococcus pyogenes induces the receptor activator of NF-kappaB ligand expression in mouse osteoblastic cells.Infect Immun2003https://conductscience.org/library/papers/12540577PubMed
12,010,973Regulatory role of interleukin-10 in experimental group B streptococcal arthritis.Infect Immun2002https://conductscience.org/library/papers/12010973PubMed
11,119,551Severity of group B streptococcal arthritis in selected strains of laboratory mice.Infect Immun2001https://conductscience.org/library/papers/11119551PubMed
10,456,898Role of tumor necrosis factor alpha, interleukin-1beta, and interleukin-6 in a mouse model of group B streptococcal arthritis.Infect Immun1999https://conductscience.org/library/papers/10456898PubMed
9,536,122The dual role of interferon-gamma in experimental Staphylococcus aureus septicaemia versus arthritis.Immunology1998https://conductscience.org/library/papers/9536122PubMed
8,540,695In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice: comparative study with erythromycin and penicillin G.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/8540695PubMed
8,454,331Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).Infect Immun1993https://conductscience.org/library/papers/8454331PubMed
8,188,356Immunopathological features of rat Staphylococcus aureus arthritis.Infect Immun1994https://conductscience.org/library/papers/8188356PubMed
7,591,086Overexpression of the T-cell receptor V beta 3 in transgenic mice increases mortality during infection by enterotoxin A-producing Staphylococcus aureus.Infect Immun1995https://conductscience.org/library/papers/7591086PubMed
1,855,981Experimental Staphylococcus aureus arthritis in mice.Infect Immun1991https://conductscience.org/library/papers/1855981PubMed
1,612,762Histopathological and serological progression of experimental Staphylococcus aureus arthritis.Infect Immun1992https://conductscience.org/library/papers/1612762PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2201646

GET https://conductscience.org/api/papers/v1/2201646/references?page=2